zu 3,00 ,-dollar , ..so wie ich das verstanden habe. Hmm, der Cashbestand war doch eigentlich recht gut ?!?
|
schwache TERN-201 (VAP-1 inhibitor) Phase 1 Daten
"While treatment with TERN-201 10 mg resulted in near complete (>98%) inhibition of plasma VAP-1 in most subjects, there were no meaningful changes in exploratory serum or imaging NASH biomarkers with TERN-201 10 mg relative to placebo"
ir.ternspharma.com/news-releases/...se-1-aviation-trial-vap-1
65 Mio. $ Offering
ir.ternspharma.com/news-releases/...n-oversubscribed-offering
|
Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
37 | Neues NASH-IPO ein Investment wert? | Ice-Nine coming | Balu4u | 09.02.24 20:42 |